Intraoperative Neuromonitoring (IONM) Market Report 2026

The intraoperative neuromonitoring market size has grown strongly in recent years. It will grow from $3.56 billion in 2025 to $3.84 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to rising demand for safer surgical procedures, growing adoption of intraoperative neuromonitoring in complex surgeries, increasing prevalence of neurological and spinal disorders, expanding hospital infrastructure in developed regions, and enhanced focus on patient safety during surgeries.

The intraoperative neuromonitoring market size is expected to see strong growth in the next few years. It will grow to $5.14 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing adoption of multimodality neuromonitoring systems, growing use of artificial intelligence for signal interpretation, rising investments in research and development for neuromonitoring technologies, expansion of minimally invasive and robotic surgeries, and increasing availability of skilled neuromonitoring professionals. Major trends in the forecast period include advancing multimodality monitoring technologies, growing integration of artificial intelligence in neuromonitoring systems, increasing development of portable and cloud-integrated devices, expanding use of real-time data analytics in surgeries, and rising innovations in wearable and intraoperative monitoring sensors.

The increasing number of complex surgeries is expected to drive the growth of the intraoperative neuromonitoring (IONM) market in the coming years. Complex surgeries are advanced medical procedures that involve higher risk levels, require specialized expertise, and often address severe or multi-system health conditions. The volume of such surgeries is rising as surgeons more frequently operate on older patients with multiple chronic conditions, including diabetes, obesity, and heart disease, supported by advancements in surgical techniques that make high-risk interventions possible. Intraoperative neuromonitoring supports complex surgical procedures by delivering real-time information on neural function, thereby reducing the risk of nerve injury during critical operations. For example, in January 2025, according to the Organ Procurement and Transplantation Network (OPTN), a US-based national organization connecting professionals in organ donation and transplantation, the total number of organ transplants in the United States reached 48,180 in 2024, reflecting a 3.3% increase from 46,632 in 2023. As a result, the growing volume of complex surgeries is contributing to the expansion of the intraoperative neuromonitoring market.

Major participants in the intraoperative neuromonitoring (IONM) market are concentrating on expanding product portfolios, including specialized disposable concentric needle families, to enhance diagnostic precision and improve workflow efficiency. Specialized disposable concentric needle families consist of disposable needles engineered to deliver consistent signal quality and accurate recording performance, reducing the variability associated with reusable devices while preserving high fidelity in electromyography (EMG) and nerve conduction velocity (NCV) studies. For example, in October 2023, Rhythmlink International LLC, a US-based medical device designer and manufacturer specializing in intraoperative neuromonitoring, introduced its Concentric Needle Family. This product line includes specialized disposable concentric needles available in four sizes, designed to be used with a reusable cable specifically developed for the system. The solution provides clinicians with a high-quality, customizable option for precisely targeting and recording activity from specific muscle areas, thereby improving the consistency and reliability of intraoperative and diagnostic neurological evaluations.

In March 2024, MPOWER Health, a US-based provider of optimized healthcare solutions and surgical support services, acquired Assure Neuromonitoring LLC for an undisclosed amount. Through this acquisition, MPOWER Health seeks to strengthen its intraoperative neuromonitoring (IONM) capabilities by incorporating Assure Neuromonitoring’s specialized clinical services and monitoring expertise, supporting enhanced patient safety, real-time neural evaluation, and improved surgical outcomes across neurological, orthopedic, and spine procedures. Assure Neuromonitoring LLC is a US-based provider of outsourced intraoperative neural signal monitoring and surgical support services.

Major companies operating in the intraoperative neuromonitoring (ionm) market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Nihon Kohden Corporation, Nuvaise Inc., Natus Medical incorporated, Speciality care Inc., Brainlab AG, Neurosoft Ltd., Cadwell industries Inc., Neuromonitoring Associates LLC, Compummedics Ltd., Inomed medizintecknic Gmbh, Accurate Neuromonitoring Inc., Electrical Geodesics Inc., Blackrock NeuroTech LLC, Neuromonitoring Technologies Inc., Tucker Davis technologies Inc., Sentient Medical Systems Inc., Dr.Langer Medical Gmbh, Moller Wedel Gmbh, Ionm Solutions Inc., Axontronic GmbH & Co. KG, Alpha Omega Engineering Ltd.

North America was the largest region in the intraoperative neuromonitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intraoperative neuromonitoring (ionm) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the intraoperative neuromonitoring (ionm) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are influencing the intraoperative neuromonitoring market by increasing costs of imported electrodes, probes, amplifiers, signal processors, and specialized monitoring software. hospitals and specialty surgical centers in north america and europe are most affected due to dependence on imported high-precision medical electronics, while asia-pacific faces increased system pricing pressures. these tariffs are raising procedural costs and extending equipment upgrade cycles. at the same time, they are supporting regional manufacturing, localized service delivery models, and domestic development of neuromonitoring technologies.

Intraoperative neuromonitoring is a clinical technique employed during surgical procedures to monitor the functional status of nerves, the spinal cord, and specific brain regions in real time. It assists surgeons in avoiding potential injury by delivering continuous feedback on neurological activity throughout the operation. This method improves patient safety by lowering the likelihood of postoperative neurological complications.

The key categories of intraoperative neuromonitoring include systems, accessories and consumables, and services. Systems are integrated platforms used during surgery to monitor nervous system function and reduce neurological risk. Monitoring approaches include insourced and outsourced models. Modalities include somatosensory and motor evoked potentials, EEG, EMG, brainstem auditory and visual evoked potentials, and others. Applications span neurosurgery, spine surgery, vascular and cardiothoracic surgery, ENT surgery, orthopedic surgery, and more, across hospitals, ambulatory surgical centers, specialty clinics, and others.

The intraoperative neuromonitoring market includes revenues earned by providing services such as real-time neural function monitoring during surgery, somatosensory evoked potential monitoring services, motor evoked potential monitoring services, electromyography monitoring services, and intraoperative neurophysiologist interpretation and reporting services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.